# BioAtla, Inc.: Form 8-K, filed Jan 11, 2022

- Company: [BioAtla, Inc.](/companies/bcab.md) (CIK 1826892)
- Form: 8-K
- Filed: 2022-01-11
- Accepted by EDGAR: Jan 10, 2022, 17:31 ET
- Period: 2022-01-05
- Accession: 0000950170-22-000220
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1826892/000095017022000220/bcab-20220105.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1826892/000095017022000220/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1826892/000095017022000220/bcab-20220105.htm

Filed Jan 11, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-000220. Last ingested by Listed: Oct 30, 2026, 06:15 ET. No prices; not investment advice.